ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,720.18
1.32%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Turning Point Therapeutics Inc (TPTX)

  7. Turning Point Therapeutics Inc (TPTX) Noticias

TPTX

Turning Point Therapeutics (TPTX)

Turning Point Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TPTX
FechaHoraFuenteTítuloSímboloCompañía
29/08/202215:31Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:TPTXTurning Point Therapeutics Inc
23/08/202205:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202215:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202208:03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202208:01Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202208:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TPTXTurning Point Therapeutics Inc
17/08/202207:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202206:11Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202206:09Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:TPTXTurning Point Therapeutics Inc
16/08/202205:59Business WireBristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point TherapeuticsNASDAQ:TPTXTurning Point Therapeutics Inc
10/08/202222:20TipRanksAnalysts Offer Insights on Healthcare Companies: Reata Pharmaceuticals (RETA), Turning Point Therapeutics (TPTX) and Talkspace (TALK)NASDAQ:TPTXTurning Point Therapeutics Inc
09/08/202223:35TipRanksJMP Securities Remains a Hold on Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
08/08/202215:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TPTXTurning Point Therapeutics Inc
08/08/202215:17GlobeNewswire Inc.Turning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational UpdatesNASDAQ:TPTXTurning Point Therapeutics Inc
31/07/202222:31TipRanksSVB Securities Maintains a Hold Rating on Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
27/07/202215:05GlobeNewswire Inc.Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLCNASDAQ:TPTXTurning Point Therapeutics Inc
24/06/202208:00GlobeNewswire Inc.Turning Point Therapeutics and MD Anderson Announce Strategic Alliance to Advance Precision Cancer TherapiesNASDAQ:TPTXTurning Point Therapeutics Inc
17/06/202215:47Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:TPTXTurning Point Therapeutics Inc
17/06/202215:44Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:TPTXTurning Point Therapeutics Inc
13/06/202221:05TipRanksAnalysts Offer Insights on Healthcare Companies: CTI BioPharma (CTIC) and Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
06/06/202206:38TipRanksWhy Are Bristol-Myers & Turning Point Made for Each Other?NASDAQ:TPTXTurning Point Therapeutics Inc
05/06/202223:25TipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Bicycle Therapeutics (BCYC), Turning Point Therapeutics (TPTX) and Globus Medical (GMED)NASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202216:16Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202209:36Dow Jones NewsTurning Point Therapeutics Shares Surge on Bristol Myers DealNASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202208:06Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:TPTXTurning Point Therapeutics Inc
03/06/202206:43Dow Jones NewsBristol Myers to Buy Turning Point Therapeutics for $4.1 BillionNASDAQ:TPTXTurning Point Therapeutics Inc
26/05/202215:30GlobeNewswire Inc.Turning Point Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:TPTXTurning Point Therapeutics Inc
16/05/202207:30GlobeNewswire Inc.Turning Point Therapeutics Announces Appointment of Steve Sabus as Chief Commercial OfficerNASDAQ:TPTXTurning Point Therapeutics Inc
11/05/202223:25TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Concert Pharma (CNCE), Clearside Biomedical (CLSD) and Turning Point Therapeutics (TPTX)NASDAQ:TPTXTurning Point Therapeutics Inc
11/05/202207:43TipRanksSVB Securities Thinks Turning Point Therapeutics’ Stock is Going to RecoverNASDAQ:TPTXTurning Point Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TPTX

Su Consulta Reciente

NYSE
XOM
Exxon Mobil
NYSE
BAC
Bank of America
AMEX
XLE
Energy Select Sector SPDR
FX
EURUSD
Euro vs US Dollar
NYSE
VZ
Verizon Communications
NYSE
CVX
Chevron
USOTC
ADDYY
Adidas (QX)
NASDAQ
NVDA
NVIDIA
FX
USDMXN
US Dollar vs MXN
PM
XAUUSD
Gold vs US Dollar
NYSE
AXP
American Express
FX
EURMXN
Euro vs MXN
AMEX
XLF
Financial Select Sector
USOTC
BNPQY
BNP Paribas (QX)
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados